Works matching IS 17470277 AND DT 2022 AND VI 100 AND IP 4
Results: 11
Pyrimidine derivatives as EGFR tyrosine kinase inhibitors in non‐small‐cell lung cancer: A comprehensive review.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Development of potent inhibitors by fragment‐linking strategies.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Investigating the active components of Huatan Tongjing decoction for the treatment of polycystic ovary syndrome via network pharmacology.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 100, n. 4, p. 515, doi. 10.1111/cbdd.14117
- By:
- Publication type:
- Article
DNA intercalators as anticancer agents.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Hydrogen bonding penalty used for virtual screening to discover potent inhibitors for Papain‐Like cysteine proteases of SARS‐CoV‐2.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 100, n. 4, p. 502, doi. 10.1111/cbdd.14115
- By:
- Publication type:
- Article
Chemical synthesis, biological activities, and molecular simulations of novel sulfonylurea compounds bearing ortho‐alkoxy substitutions.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 100, n. 4, p. 487, doi. 10.1111/cbdd.14114
- By:
- Publication type:
- Article
Design, synthesis, antibacterial activity evaluation and molecular docking study of pleuromutilin derivatives bearing amide side chains.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 100, n. 4, p. 564, doi. 10.1111/cbdd.14106
- By:
- Publication type:
- Article
Novel serratiopeptidase exhibits different affinities to the substrates and inhibitors.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 100, n. 4, p. 553, doi. 10.1111/cbdd.14105
- By:
- Publication type:
- Article
Design and synthesis of five‐membered heterocyclic derivatives of istradefylline with comparable pharmacological activity.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 100, n. 4, p. 534, doi. 10.1111/cbdd.14067
- By:
- Publication type:
- Article
Structure‐based discovery of Licoflavone B and Ginkgetin targeting c‐Myc G‐quadruplex to suppress c‐Myc transcription and myeloma growth.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 100, n. 4, p. 525, doi. 10.1111/cbdd.14064
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Chemical Biology & Drug Design, 2022, v. 100, n. 4, p. i, doi. 10.1111/cbdd.13887
- Publication type:
- Article